Preflight screening techniques for centrifuge-simulated suborbital spaceflight

James M. Pattarini, Rebecca Blue, Tarah L. Castleberry, James M. Vanderploeg

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Historically, space has been the venue of the healthy individual. With the advent of commercial spaceflight, we face the novel prospect of routinely exposing spaceflight participants (SPFs) with multiple comorbidities to the space environment. Preflight screening procedures must be developed to identify those individuals at increased risk during flight. We examined the responses of volunteers to centrifuge accelerations mimicking commercial suborbital spaceflight profiles to evaluate how potential SFPs might tolerate such forces. We evaluated our screening process for medical approval of subjects for centrifuge participation for applicability to commercial spaceflight operations. Methods: All registered subjects completed a medical questionnaire, physical examination, and electrocardiogram. Subjects with identified concerns including cardiopulmonary disease, hypertension, and diabetes were required to provide documentation of their conditions. Results: There were 335 subjects who registered for the study, 124 who completed all prescreening, and 86 subjects who participated in centrifuge trials. Due to prior medical history, five subjects were disqualified, most commonly for psychiatric reasons or uncontrolled medical conditions. Of the subjects approved, four individuals experienced abnormal physiological responses to centrifuge profiles, including one back strain and three with anxiety reactions. Discussion: The screening methods used were judged to be sufficient to identify individuals physically capable of tolerating simulated suborbital flight. Improved methods will be needed to identify susceptibility to anxiety reactions. While severe or uncontrolled disease was excluded, many subjects successfully participated in centrifuge trials despite medical histories of disease that are disqualifying under historical spaceflight screening regimes. Such screening techniques are applicable for use in future commercial spaceflight operations.

Original languageEnglish (US)
Pages (from-to)1217-1221
Number of pages5
JournalAviation Space and Environmental Medicine
Volume85
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Space Flight
Anxiety
Documentation
Physical Examination
Psychiatry
Comorbidity
Volunteers
Electrocardiography
Hypertension

Keywords

  • Cardiovascular disease
  • Commercial spaceflight participant
  • Diabetes
  • Hypergravity
  • Hypertension
  • Medical risk
  • Medical screening
  • Pulmonary disease

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Preflight screening techniques for centrifuge-simulated suborbital spaceflight. / Pattarini, James M.; Blue, Rebecca; Castleberry, Tarah L.; Vanderploeg, James M.

In: Aviation Space and Environmental Medicine, Vol. 85, No. 12, 2014, p. 1217-1221.

Research output: Contribution to journalArticle

Pattarini, James M. ; Blue, Rebecca ; Castleberry, Tarah L. ; Vanderploeg, James M. / Preflight screening techniques for centrifuge-simulated suborbital spaceflight. In: Aviation Space and Environmental Medicine. 2014 ; Vol. 85, No. 12. pp. 1217-1221.
@article{2ab7d79be9134c7ca2c7e624c2e28f4a,
title = "Preflight screening techniques for centrifuge-simulated suborbital spaceflight",
abstract = "Introduction: Historically, space has been the venue of the healthy individual. With the advent of commercial spaceflight, we face the novel prospect of routinely exposing spaceflight participants (SPFs) with multiple comorbidities to the space environment. Preflight screening procedures must be developed to identify those individuals at increased risk during flight. We examined the responses of volunteers to centrifuge accelerations mimicking commercial suborbital spaceflight profiles to evaluate how potential SFPs might tolerate such forces. We evaluated our screening process for medical approval of subjects for centrifuge participation for applicability to commercial spaceflight operations. Methods: All registered subjects completed a medical questionnaire, physical examination, and electrocardiogram. Subjects with identified concerns including cardiopulmonary disease, hypertension, and diabetes were required to provide documentation of their conditions. Results: There were 335 subjects who registered for the study, 124 who completed all prescreening, and 86 subjects who participated in centrifuge trials. Due to prior medical history, five subjects were disqualified, most commonly for psychiatric reasons or uncontrolled medical conditions. Of the subjects approved, four individuals experienced abnormal physiological responses to centrifuge profiles, including one back strain and three with anxiety reactions. Discussion: The screening methods used were judged to be sufficient to identify individuals physically capable of tolerating simulated suborbital flight. Improved methods will be needed to identify susceptibility to anxiety reactions. While severe or uncontrolled disease was excluded, many subjects successfully participated in centrifuge trials despite medical histories of disease that are disqualifying under historical spaceflight screening regimes. Such screening techniques are applicable for use in future commercial spaceflight operations.",
keywords = "Cardiovascular disease, Commercial spaceflight participant, Diabetes, Hypergravity, Hypertension, Medical risk, Medical screening, Pulmonary disease",
author = "Pattarini, {James M.} and Rebecca Blue and Castleberry, {Tarah L.} and Vanderploeg, {James M.}",
year = "2014",
doi = "10.3357/ASEM.4114.2014",
language = "English (US)",
volume = "85",
pages = "1217--1221",
journal = "Aerospace medicine and human performance",
issn = "2375-6314",
publisher = "Aerospace Medical Association",
number = "12",

}

TY - JOUR

T1 - Preflight screening techniques for centrifuge-simulated suborbital spaceflight

AU - Pattarini, James M.

AU - Blue, Rebecca

AU - Castleberry, Tarah L.

AU - Vanderploeg, James M.

PY - 2014

Y1 - 2014

N2 - Introduction: Historically, space has been the venue of the healthy individual. With the advent of commercial spaceflight, we face the novel prospect of routinely exposing spaceflight participants (SPFs) with multiple comorbidities to the space environment. Preflight screening procedures must be developed to identify those individuals at increased risk during flight. We examined the responses of volunteers to centrifuge accelerations mimicking commercial suborbital spaceflight profiles to evaluate how potential SFPs might tolerate such forces. We evaluated our screening process for medical approval of subjects for centrifuge participation for applicability to commercial spaceflight operations. Methods: All registered subjects completed a medical questionnaire, physical examination, and electrocardiogram. Subjects with identified concerns including cardiopulmonary disease, hypertension, and diabetes were required to provide documentation of their conditions. Results: There were 335 subjects who registered for the study, 124 who completed all prescreening, and 86 subjects who participated in centrifuge trials. Due to prior medical history, five subjects were disqualified, most commonly for psychiatric reasons or uncontrolled medical conditions. Of the subjects approved, four individuals experienced abnormal physiological responses to centrifuge profiles, including one back strain and three with anxiety reactions. Discussion: The screening methods used were judged to be sufficient to identify individuals physically capable of tolerating simulated suborbital flight. Improved methods will be needed to identify susceptibility to anxiety reactions. While severe or uncontrolled disease was excluded, many subjects successfully participated in centrifuge trials despite medical histories of disease that are disqualifying under historical spaceflight screening regimes. Such screening techniques are applicable for use in future commercial spaceflight operations.

AB - Introduction: Historically, space has been the venue of the healthy individual. With the advent of commercial spaceflight, we face the novel prospect of routinely exposing spaceflight participants (SPFs) with multiple comorbidities to the space environment. Preflight screening procedures must be developed to identify those individuals at increased risk during flight. We examined the responses of volunteers to centrifuge accelerations mimicking commercial suborbital spaceflight profiles to evaluate how potential SFPs might tolerate such forces. We evaluated our screening process for medical approval of subjects for centrifuge participation for applicability to commercial spaceflight operations. Methods: All registered subjects completed a medical questionnaire, physical examination, and electrocardiogram. Subjects with identified concerns including cardiopulmonary disease, hypertension, and diabetes were required to provide documentation of their conditions. Results: There were 335 subjects who registered for the study, 124 who completed all prescreening, and 86 subjects who participated in centrifuge trials. Due to prior medical history, five subjects were disqualified, most commonly for psychiatric reasons or uncontrolled medical conditions. Of the subjects approved, four individuals experienced abnormal physiological responses to centrifuge profiles, including one back strain and three with anxiety reactions. Discussion: The screening methods used were judged to be sufficient to identify individuals physically capable of tolerating simulated suborbital flight. Improved methods will be needed to identify susceptibility to anxiety reactions. While severe or uncontrolled disease was excluded, many subjects successfully participated in centrifuge trials despite medical histories of disease that are disqualifying under historical spaceflight screening regimes. Such screening techniques are applicable for use in future commercial spaceflight operations.

KW - Cardiovascular disease

KW - Commercial spaceflight participant

KW - Diabetes

KW - Hypergravity

KW - Hypertension

KW - Medical risk

KW - Medical screening

KW - Pulmonary disease

UR - http://www.scopus.com/inward/record.url?scp=84916598248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916598248&partnerID=8YFLogxK

U2 - 10.3357/ASEM.4114.2014

DO - 10.3357/ASEM.4114.2014

M3 - Article

C2 - 25479265

AN - SCOPUS:84916598248

VL - 85

SP - 1217

EP - 1221

JO - Aerospace medicine and human performance

JF - Aerospace medicine and human performance

SN - 2375-6314

IS - 12

ER -